Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D4SE2H
|
|||
| Drug Name |
Humantakinogene hadenovec
|
|||
| Drug Type |
Gene therapy
|
|||
| Indication | Osteoarthritis [ICD-11: FA00-FA05; ICD-9: 715] | Phase 1 | [1] | |
| Company |
Flexion Therapeutics
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Interleukin-1 receptor antagonist protein (IL1RN) | Target Info | . | [1] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT04119687) An Open-Label, Single Ascending Dose Study to Assess the Safety and Tolerability of FX201 in Patients With Osteoarthritis of the Knee. U.S.National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.